We are pleased that the UK NEQAS Clinical Chemistry division are holding a series of face-to-face meetings for our participants in 2025. These are in-person meetings; there is not a Teams / Zoom / Dial-in option. We will not be recording the meetings.

The meetings will focus on why EQA is important for patient safety, and where EQA data has made a real difference to patient care.

The meeting will be relevant to participants in schemes from all UK NEQAS Chemistry centres:

• Birmingham Quality
• Cardiac Markers
• Edinburgh Peptide Hormones
• Guildford Peptide Hormones
• Guildford Trace Elements

We will be travelling around the country, to make it easy for everyone to attend one of the meetings. Dates of the meetings and links to registration are below:

• London – Thursday 1^st May – "etc. venues", Marble Arch
https://wheldonevents.co.uk/online-registration/ukneqas-london/
• Manchester – Friday 9^th May – "etc. venues", Piccadilly
https://wheldonevents.co.uk/online-registration/ukneqas-manchester/
• Edinburgh – Thursday 19^th June – Radisson Blu Hotel, The Royal Mile
https://wheldonevents.co.uk/online-registration/ukneqas-edinburgh/
• Dublin – Friday 12^th September – Hilton Dublin Hotel, Charlemont Place
https://wheldonevents.co.uk/online-registration/uk-neqas-dublin/

Please note that while the meetings are free to attend for UK NEQAS Participants, there will be a charge for non-attendance of £100 per participant. If you register and find yourself unable to attend, please let us know and we can transfer your place to a nominated colleague.

We look forward to seeing you there!

Time	Session
09:00 – 10:00	Arrival and Registration (Refreshments available)
10:00 – 10:40	Introduction: What EQA Is and What it Isn’t Rachel Marrington Consultant Clinical Scientist and Deputy Director Birmingham Quality
10:40 – 11:20	Hot Topics in Routine Clinical Chemistry EQA Finlay MacKenzie Consultant Clinical Scientist and Director Birmingham Quality
11:20 – 11:40	Coffee Break
11:40 – 12:20	How EQA Can Be Used to Assess Interferences in Assays Gwen Wark Consultant Clinical Scientist & Scheme Director UK NEQAS Guildford Peptide Hormones and Trace Elements
12:20 – 13:00	Challenges in the Measurement of Prolactin Catharine Sturgeon Consultant Clinical Scientist and Director UK NEQAS [Edinburgh] (Peptide Hormones)
13:00 – 13:50	Lunch
13:50 – 14:30	Interactive Discussion Session – How do you review your EQA reports?
14:30 – 14:35	Coffee/Comfort Break
14:35 – 15:15	Interactive Discussion Session – What do you look for in an EQA scheme?
15:15 – 15:30	Feedback from Interactive Discussion Sessions
15:30 – 16:00	Using EQA Data to Manage Clinical Risk Naomi Elkin Principal Clinical Scientist and Scheme Director UK NEQAS Cardiac Markers
16:00 – 16:05	Close